Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042109 (
urticaria
)
6,569
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Immediate hypersensitivity responses, as acute
urticaria
, produce a release of neuropeptides by nerve endings, which present specificity of recognition by mast cells, basophils and other target cells. We have measured vasoactive intestinal peptide (VIP), somatostatin,
bombesin
, neurotensin and beta-endorphin by radioimmunoassay in plasma extracts of 20 patients with acute idiopathic
urticaria
and of 20 healthy subjects. VIP- and beta-endorphin-like immunoreactivities were found to be significantly decreased with respect to controls (p less than 0.001 and p less than 0.01, respectively). On the contrary, somatostatin- and
bombesin
-like immunoreactivities were significantly increased (p less than 0.001 and p less than 0.05, respectively). These findings could be a reflection in blood of a raised release of somatostatin and
bombesin
by nerve endings in the
urticaria
process. Moreover, the decreased plasma levels of VIP- and beta-endorphin-like immunoreactivities could be explained by a raised specific metabolism of these peptides in the
urticaria
process.
...
PMID:Plasma neuropeptide pattern in acute idiopathic urticaria. 257 76